Clinical Trial Update: Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating erenumab for adult chronic migraine has completed and posted results. The update summarizes the efficacy and safety findings from the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2025-05-11